Download MendeleyA Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins.
Ackloo, S., Li, F., Szewczyk, M., Seitova, A., Loppnau, P., Zeng, H., Xu, J., Ahmad, S., Arnautova, Y.A., Baghaie, A.J., Beldar, S., Bolotokova, A., Centrella, P.A., Chau, I., Clark, M.A., Cuozzo, J.W., Dehghani-Tafti, S., Disch, J.S., Dong, A., Dumas, A., Feng, J.A., Ghiabi, P., Gibson, E., Gilmer, J., Goldman, B., Green, S.R., Guie, M.A., Guilinger, J.P., Harms, N., Herasymenko, O., Houliston, S., Hutchinson, A., Kearnes, S., Keefe, A.D., Kimani, S.W., Kramer, T., Kutera, M., Kwak, H.A., Lento, C., Li, Y., Liu, J., Loup, J., Machado, R.A.C., Mulhern, C.J., Perveen, S., Righetto, G.L., Riley, P., Shrestha, S., Sigel, E.A., Silva, M., Sintchak, M.D., Slakman, B.L., Taylor, R.D., Thompson, J., Torng, W., Underkoffler, C., von Rechenberg, M., Walsh, R.T., Watson, I., Wilson, D.J., Wolf, E., Yadav, M., Yazdi, A.K., Zhang, J., Zhang, Y., Santhakumar, V., Edwards, A.M., Barsyte-Lovejoy, D., Schapira, M., Brown, P.J., Halabelian, L., Arrowsmith, C.H.(2025) J Med Chem 68: 1092-1112
- PubMed: 39495097
- DOI: https://doi.org/10.1021/acs.jmedchem.4c02010
- Primary Citation of Related Structures:
8UWP - PubMed Abstract:
Target class-focused drug discovery has a strong track record in pharmaceutical research, yet public domain data indicate that many members of protein families remain unliganded. Here we present a systematic approach to scale up the discovery and characterization of small molecule ligands for the WD40 repeat (WDR) protein family. We developed a comprehensive suite of protocols for protein production, crystallography, and biophysical, biochemical, and cellular assays. A pilot hit-finding campaign using DNA-encoded chemical library selection followed by machine learning (DEL-ML) to predict ligands from virtual libraries yielded first-in-class, drug-like ligands for 7 of the 16 WDR domains screened, thus demonstrating the broader ligandability of WDRs. This study establishes a template for evaluation of protein family wide ligandability and provides an extensive resource of WDR protein biochemical and chemical tools, knowledge, and protocols to discover potential therapeutics for this highly disease-relevant, but underexplored target class.
Organizational Affiliation:
Structural Genomics Consortium, University of Toronto, 101 College St., Toronto, ON M5G 1L7, Canada.
